SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-18-004218
Filing Date
2018-04-10
Accepted
2018-04-10 10:45:17
Documents
7
Period of Report
2018-04-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k041018_xtlbiopharma.htm 6-K 15479
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S EXTRAORDINARY GENERAL M f6k041018ex99-1_xtlbio.htm EX-99.1 49024
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S EXTRAORD f6k041018ex99-2_xtlbio.htm EX-99.2 15219
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHARE HOLDERS WITH RESPECT TO TH f6k041018ex99-3_xtlbio.htm EX-99.3 1561
5 GRAPHIC ex99-1_001.jpg GRAPHIC 9243
6 GRAPHIC ex99-3_001.jpg GRAPHIC 88877
7 GRAPHIC ex99-3_002.jpg GRAPHIC 89532
  Complete submission text file 0001213900-18-004218.txt   341131
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 18747139
SIC: 2834 Pharmaceutical Preparations